loading

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$61.73
price up icon 3.42%
$113.12
price up icon 21.96%
$130.66
price up icon 1.71%
$242.61
price up icon 6.12%
ONC ONC
$376.86
price up icon 2.09%
$214.66
price down icon 0.62%
Kapitalisierung:     |  Volumen (24h):